license

Cyprumed and MSD Enter Licensing Agreement for Oral Peptide Therapeutics

MSD receives a non-exclusive license for Cyprumed's drug delivery technology for developing oral peptide therapeutics.

ECI Group Secures First 150kta Copolymer License

ECI Group recently announced the signing of a licensing agreement with Shaanxi Yanchang China Coal Yulin Energy & Chemical Co., Ltd. (YECC) to deliver a 150kta copolymer plant project using ECI Group’s proprietary hybrid reactor technology.

News

Air Liquide Takes MCC Butene License

News

NatureWorks Picks Plaxica’s D-lactic Acid Process

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Interview

Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Merck & Co

Engineers and Constructors International, Inc. (ECI)